ZCMD:NASDAQZhongchao Inc. Analysis
Data as of 2026-05-12 - not real-time
$1.52
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Zhongchao Inc. (ZCMD) is trading at the lower end of its 52‑week range, barely above the identified support level of $1.52, while the 30‑day volatility exceeds 100% and the RSI sits at 28, signaling an oversold condition. Technical indicators such as a bearish MACD histogram and a neutral trend direction suggest limited upside momentum in the near term, yet the increasing volume hints at potential buying interest. Fundamentally, the company’s DCF fair value of roughly $12.60 dwarfs the current market price, indicating a deep discount, and the balance sheet is strong with over $13.9 million in cash against negligible debt. However, the business is currently loss‑making, with negative operating and profit margins and a massive historical drawdown of over 87%, which raises concerns about the sustainability of earnings. The sector—health information services—offers medium‑term growth prospects, but regulatory scrutiny in China and the firm’s reliance on the domestic market add layers of risk. Given the blend of extreme undervaluation, solid liquidity, and high volatility, investors should weigh the upside potential against the substantial execution and regulatory uncertainties.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- RSI indicates oversold conditions but MACD remains bearish
- Price is at immediate support with limited upside catalyst
- Extreme short‑term volatility may produce erratic price swings
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF valuation suggests >700% upside potential
- Strong cash position and minimal debt provide financial flexibility
- Potential recovery in Chinese digital health education market
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Secular trend toward online medical education and tele‑health services
- Opportunity to monetize patient‑management platforms as regulations evolve
- Undervalued balance sheet could support strategic acquisitions or partnerships
Key Metrics & Analysis
Financial Health
Revenue Growth-23.20%
Profit Margin-55.47%
ROE-24.88%
ROA-15.47%
Debt/Equity0.12
P/B Ratio0.2
Op. Cash Flow$845.4K
Free Cash Flow$2.6M
Industry P/E26.4
Technical Analysis
TrendNeutral
RSI28.1
Support$1.52
Resistance$2.29
MA 20$2.05
MA 50$1.90
MA 200$4.77
MACDBearish
VolumeIncreasing
Fear & Greed Index87.91
Valuation
Fair Value$12.60
GradeUndervalued
TypeValue
Risk Assessment
Beta1.25
Volatility102.09%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
ZKH
ZKH Group Limited
STOCKZJYL
JIN MEDICAL INTERNATIONAL LTD.
STOCKZJK
ZJK Industrial Co., Ltd.
STOCKZIP
ZipRecruiter, Inc.
STOCKZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKZION
Zions Bancorporation N.A.
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.